ОЁҚ ВА ҚЎЛЛАРДАГИ ЮМШОҚ ТЎҚИМА САРКОМАЛАРИНИНГ ДАВОЛАШ УСУЛЛАРИ
Abstrak
Сўнгги йилларда оёқ ва қўллар ЮТС билан касалланган беморларни даволаш сезиларли даражада ўзгарди, бу асосан онкология соҳасида содир бўлган ўзгаришларни акс эттиради. Охирги 10-15 йил ичида ампутациялар сони 5-18% гача камайди Xулоса: Касалликка чалинган беморларнинг 50% дан ортиғи меҳнатга лаёқатли ёшдаги инсонлар бўлиб, ривожланган давлатларда 1 йиллик ўлим кўрсаткичи 26% ва 5 йиллик яшовчанлик кўрсаткичи эса 30%дан юқорилиги бу касалликнинг кескин агрессив кечишидан дарак беради. Kалит сўзлар: юмшоқ тўқималар саркомаси, даволаш, яшовчанлик кўрсаткичи.
##submission.citations##
1. Nicolazzo C, Gradilone A. Significance of circulating tumor cells in soft tissue sarcoma. Anal Cell Pathol. 2015;
2. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO Lyon, IARC Press. 2013. Classification of tumours of soft tissue and bone. 4th edition.
3. National Comprehensive Cancer Network Soft Tissue Sarcoma. (ver. 2.2019). 2019.
4. Mertens F, Antonescu CR, Hohenberger P, Ladanyi M, Modena P, D’Incalci M, Casali PG, Aglietta M, Alvegård T. Translocation-related sarcomas. Semin Oncol. 2009;36(4):312–323.
5. Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CDM, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: an analysis of 26,758 cases. Int J Cancer. 2006; 119 : 2922–2930.
6. Jo VY, Fletcher CDM: WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology 2014,46.
7. Hoefkens F, Dehandschutter C, Somville J, Meijnders P, Van Gestel D. Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy. Radiat Oncol. 2016; 11:136. 10.1186/s13014-016-0668-9
8. Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Ganjoo KN, George S, Gonzalez RJ, Heslin MJ, Kane JM 3rd, Keedy V, Kim E, Koon H, et al.. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018; 16:536–63. 10.6004/jnccn.2018.0025
9. Honoré C, Méeus P, Stoeckle E, Bonvalot S. Soft tissue sarcoma in France in 2015: Epidemiology, classification and organization of clinical care. J Visc Surg. 2015; 152:223–30. 10.1016/j.jviscsurg.2015.05.
10. Fletcher CDM. WHO Classification of Tumours of Soft Tissue and Bone. World Health Organization; 2013;
11. Chibon F, Aurias A, Coindre JM. Cancer Genomics. Dordrecht: Springer Netherlands; 2013. Sarcomas Genetics: From Point Mutation to Complex Karyotype, from Diagnosis to Therapies; pp. 429–52.
12. Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO Lyon, IARC Press. 2013. Classification of tumours of soft tissue and bone. 4th edition.
13. National Comprehensive Cancer Network Soft Tissue Sarcoma. (ver. 2.2019). 2019.
14. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Cli. 57:43–66. 2007.
15. Fernebro J, Bladström A, Rydholm A, Gustafson P, Olsson H, Engellau J and Nilbert M: Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patients. Br J Cancer. 95:986–990. 2006.
16. Billingsley KG, Lewis JJ, Leung DH, Casper ES, Woodruff JM and Brennan MF: Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma. Cancer. 85:389–395. 1999.
17. Gronchi A, Casali PG, Mariani L, Miceli R, Fiore M, Lo Vullo S, Bertulli R, Collini P, Lozza L, Olmi P, et al: Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: A series of patients treated at a single institution. J Clin Oncol. 23:96–104. 2005.
18. A. de Juan Ferre, R. Alvarez Alvarez and other SEOM Clinical Guideline of management of soft-tissue sarcoma 2020.
19. Canadian Cancer Statistics. 2015. pp. 1–151
20. Kim HS, Nam CM, Jang S-Y, Choi SK, Han M, Kim S, Moneta MV, Lee SY, Cho JM, Novick D, Rha SY. Characteristics and treatment patterns of patients with advanced soft tissue sarcoma in iKorea. Cancer Research And Treatment: Official Journal of Korean Cancer Association. 2019;51:1380–1391.
21. Bessen T, Caughey GE, Shakib S, Potter JA, Reid J, Farshid G, Roder D, Neuhaus SJ. A population-based study of soft tissue sarcoma incidence and survival in Australia: an analysis of 26,970 cases. Cancer Epidemiol. 2019;63:101590.
